Because of the high prevalence of dyslipoproteinemias and their association with atherosclerotic cardiovascular disease (CVD), measurements of plasma lipids, lipoproteins, and apolipoproteins are often required for diagnosis and follow-up of patients. We will establish techniques for the detection and quantitative measurement of diagnostically important lipoproteins, [e.g., Lp (a)] and apolipoproteins (e.g., apo E).

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010206-01
Application #
3838008
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code